article · The Egyptian Journal of Radiology and Nuclear Medicine
Abstract Background Preeclampsia is a major cause of maternal and neonatal morbidity and mortality with a prevalence in Egypt (6–10.7%) exceeding global averages. Beyond conventional Doppler assessment, placental dysfunction occurs at a microstructural level that may not be detected by macrovascular indices. Shear wave elastography (SWE) enables quantitative assessment of placental stiffness; however, its regional heterogeneity and prognostic relevance to neonatal outcomes remain insufficiently explored. Objectives This study evaluated the novel role of regional placental SWE mapping, with particular focus on the maternal-central placental region, for predicting composite adverse neonatal outcomes in preeclamptic pregnancies, and compared SWE values between preeclamptic and low-risk pregnancies across disease severity subgroups. Methods A prospective study was conducted including 88 third-trimester pregnancies (44 preeclampsia, 44 controls). SWE was performed using a systematic regional mapping approach, assessing maternal-central, maternal-peripheral, fetal-central, and fetal-peripheral placental regions. Diagnostic performance was evaluated using ROC analysis and correlation with composite neonatal outcomes. Results Placental stiffness was significantly increased in preeclamptic pregnancies across all regions ( p < 0.001), with a distinct regional gradient, most pronounced in the maternal-central region. This region demonstrated the highest diagnostic performance for neonatal outcomes AUC of 0.88 (95% CI 0.80–0.96) and strongest correlation with composite adverse neonatal outcomes ( r = 0.58, p < 0.001). At an exploratory cut-off > 20.0 kPa, it achieved 84.2% (95% CI 65.3–93.6) sensitivity, 88.9% (95% CI 78.8–94.5) specificity, and 86.4% (95% CI 77.7–92.0) accuracy. SWE values also increased significantly with disease severity ( p < 0.05), supporting a dose–response relationship between placental stiffness and clinical severity. Conclusions Regional placental SWE mapping, particularly of the maternal-central zone, offers added diagnostic value over global placental assessment for predicting composite adverse neonatal outcomes in preeclampsia. SWE values increased significantly with disease severity, supporting its role as a marker of disease burden, and may serve as a quantitative biomarker for risk stratification pending validation in larger, multicenter cohorts.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1186/s43055-026-01846-5
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.